Emerging trends in contract research industry in India.

  title={Emerging trends in contract research industry in India.},
  author={Sushma Drabu and Alka Gupta and Anupama Bhadauria},
  journal={Contemporary clinical trials},
  volume={31 5},

Corporate strategies adopted by Indian Pharmaceutical Industry for restructuring

The Indian pharmaceutical industry has developed rapidly over the last few decades. Before TRIPS, the Indian regulatory system recognized only process patents. The Indian Pharmaceutical companies

Contract research organizations: an industry analysis

Purpose – The aging of the population, high prevalence of chronic diseases, and increased need for evidence‐based practice are factors that have boosted a high demand for clinical trials in the

Outsourcing of Regulatory Affairs Tasks in Pharmaceutical Companies—Why and What?

PurposeThe purpose of this study was to investigate what kind of regulatory affairs tasks is outsourced in the pharmaceutical industry and what are the reasons for outsourcing in the EU

Why Should One Choose Pharmacy as a Career

There is an enormous career opportunity for pharmaceutical professionals in the pharmaceutical industry but only those which are having progressive attitude and confidence are needed.

Collaboration versus outsourcing: the need to think outside the box.

Current outsourcing and collaboration strategies are reviewed to provide a perspective on how great knowledge sharing could help revise the drug-discovery process and, thus, move towards a more genuine collaborative process.

Rise of Clinical Trials Industry in India: An Analysis

The paper examines the ideological underpinnings of the rise of clinical trials industry in India in detail and how the ruling classes of India have tried to capitalize on this as a great economic opportunity and in the process the interests of India’s poor have been the main casualty.

The Changing Geography of Clinical Research: A Critical Analysis of Its Drivers

Research and development activities have become more and more internationalized with emerging economies playing an increasingly important role. This phenomenon is particularly debated in the

Driving force from authorities: the evolution of innovation system for biomedical industry in China

China’s biomedical innovation system will be examined and the leading role of Chinese authorities will be explored from the perspective of Triple Helix theory, with Shanghai case highlighted as the ‘highland of innovation’.

Discontinued drugs in 2012: cardiovascular drugs

The analysis of cardiovascular drugs dropped from clinical development in 2012 shows that the attrition is highest in Phase II trials and financial and strategic factors and lack of clinical efficacy are the principal reasons for these disappointments.



Entering the contract research industry in India.

Clinical research opportunities in India: Beyond the future

India is emerging as a global hub for clinical research. According to projections from McKinsey & Company, the Indian clinical research industry could attract US $1.5 billion of revenue from U.S. and

Clinical trials in India.

Setting standards for proactive pharmacovigilance in India: The way forward

The various strategies and proposals to build, maintain and implement a robust pharmacovigilance system for various stakeholders and eventually make it happen in India are described and discussed.

A new colonialism?--Conducting clinical trials in India.

A new rule enacted by the government of India that allows foreign pharmaceutical companies and other interested parties to conduct clinical trials of new drugs in India at the same time that trials of the same phase are being conducted in other countries is discussed.

Use and limitations of checklists. Other strategies for audits and inspections

Checklists are tools commonly used by quality assurance (QA) unit professionals in inspections and audits as they perform their customary tasks of verifying and checking compliance with various

National pharmacovigilance programme